Asset Details
Do you wish to reserve the book?
Review of Biological Agents in the Therapeutic Management of Monogenic Genodermatoses
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Review of Biological Agents in the Therapeutic Management of Monogenic Genodermatoses
Do you wish to request the book?
Review of Biological Agents in the Therapeutic Management of Monogenic Genodermatoses
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Review of Biological Agents in the Therapeutic Management of Monogenic Genodermatoses
2026
Overview
Monogenic genodermatoses encompass a diverse group of over 400 distinct disorders, presenting significant therapeutic challenges. Recent advancements in the clinical application of biological agents have heralded a new era in the management of these conditions. A plethora of clinical studies and case reports have demonstrated the efficacy of TNF‐α, IL‐1, IL‐4Rα, IL‐17A, IL‐12/23, and IL‐6R inhibitors in the management of monogenic genodermatoses. To elucidate the current landscape of biological agent utilization and their putative mechanisms of action in the context of monogenic genodermatoses, we conducted a review of the literature.
Publisher
John Wiley & Sons, Inc
Subject
